1. Home
  2. VTSI vs ELTX Comparison

VTSI vs ELTX Comparison

Compare VTSI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTSI
  • ELTX
  • Stock Information
  • Founded
  • VTSI 1993
  • ELTX 2011
  • Country
  • VTSI United States
  • ELTX United States
  • Employees
  • VTSI N/A
  • ELTX N/A
  • Industry
  • VTSI Miscellaneous manufacturing industries
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VTSI Consumer Discretionary
  • ELTX Health Care
  • Exchange
  • VTSI Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • VTSI 67.3M
  • ELTX 121.7M
  • IPO Year
  • VTSI N/A
  • ELTX N/A
  • Fundamental
  • Price
  • VTSI $6.25
  • ELTX $8.09
  • Analyst Decision
  • VTSI Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • VTSI 1
  • ELTX 2
  • Target Price
  • VTSI $7.00
  • ELTX $9.50
  • AVG Volume (30 Days)
  • VTSI 160.8K
  • ELTX 48.3K
  • Earning Date
  • VTSI 08-11-2025
  • ELTX 08-12-2025
  • Dividend Yield
  • VTSI N/A
  • ELTX N/A
  • EPS Growth
  • VTSI N/A
  • ELTX N/A
  • EPS
  • VTSI 0.19
  • ELTX N/A
  • Revenue
  • VTSI $26,164,645.00
  • ELTX N/A
  • Revenue This Year
  • VTSI $9.92
  • ELTX N/A
  • Revenue Next Year
  • VTSI $16.54
  • ELTX N/A
  • P/E Ratio
  • VTSI $32.87
  • ELTX N/A
  • Revenue Growth
  • VTSI N/A
  • ELTX N/A
  • 52 Week Low
  • VTSI $3.57
  • ELTX $3.70
  • 52 Week High
  • VTSI $9.40
  • ELTX $9.99
  • Technical
  • Relative Strength Index (RSI)
  • VTSI 49.81
  • ELTX 62.14
  • Support Level
  • VTSI $6.40
  • ELTX $7.76
  • Resistance Level
  • VTSI $6.71
  • ELTX $8.94
  • Average True Range (ATR)
  • VTSI 0.43
  • ELTX 0.37
  • MACD
  • VTSI -0.07
  • ELTX -0.03
  • Stochastic Oscillator
  • VTSI 21.77
  • ELTX 51.09

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: